Northbend's 1970-Unit Proposal at Corporate Square

Northbend, a 1970-unit mixed-use project by Third & Urban, proposed for Brookhaven.

Third & Urban Unveils $605M Northbend Mixed-Use Overhaul of Corporate  Square in Atlanta
Third & Urban Unveils $605M Northbend Mixed-Use Overhaul of Corporate Square in AtlantaImage via Traded

Northbend, a 1970-unit mixed-use project, is proposed for Corporate Square, a 32-acre site between I-85 and Buford Highway in Brookhaven, Atlanta. Developed by Third & Urban, it includes 350 hotel rooms.

Third & Urban to Launch $605M Atlanta Office Park Transformation - Connect  CRE
Third & Urban to Launch $605M Atlanta Office Park Transformation - Connect CREImage via Connect CRE
The Atlanta Brief

Free · unsubscribe anytime · no spam, just projects

Amenities feature a 1-acre public plaza and 5 acres of green space. Sidewalks and trails will connect to the Peachtree Creek Greenway. Public art and corporate housing are also planned.

Third & Urban, HighBrook Investors Acquire Corporate Square in Atlanta,  Plan $605M Mixed-Use Redevelopment - REBusinessOnline
Third & Urban, HighBrook Investors Acquire Corporate Square in Atlanta, Plan $605M Mixed-Use Redevelopment - REBusinessOnlineImage via REBusinessOnline

Northbend aims for LEED Neighborhood Development certification, focusing on sustainability. Notably, it lacks affordable housing units.

30-acre overhaul of office campus along I-85 takes key step forward |  Urbanize Atlanta
30-acre overhaul of office campus along I-85 takes key step forward | Urbanize AtlantaImage via Urbanize Atlanta
The Atlanta Brief

Every new development in Atlanta — tracked from permits and filings, delivered every morning at 8.

Free · unsubscribe anytime · no spam, just projects

NorthbendApproved
Address
Corporate Square Boulevard (1, 2, 3, 7, 8, 9, 11, 12, 13, and 54 Corporate Boulevard), Brookhaven, Georgia
Units
1,720
Completion
Dec 30, 2028

The Project File tracks every fact, change, company, and article we have on this development — approved as of our latest research.